In vitro activity and serum protein-binding of cefaclor

Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.

Anaerobe·2016

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.

Antimicrobial agents and chemotherapy·2015

Activity of a novel cyclic lipopeptide, CB-183,315, against resistant Clostridium difficile and other Gram-positive aerobic and anaerobic intestinal pathogens.

Antimicrobial agents and chemotherapy·2012

Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.

Anaerobe·2011

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.

Antimicrobial agents and chemotherapy·2007

Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.

Journal of chemotherapy (Florence, Italy)·2006

Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis.

The Journal of antimicrobial chemotherapy·2026

Performance of plasma separation cards for HIV drug-resistance genotyping in a resource-limited setting: comparison with plasma samples.

The Journal of antimicrobial chemotherapy·2026

Antibiotic consumption in HIV and PrEP populations with and without sexually transmitted infections: a population-based observational study.

The Journal of antimicrobial chemotherapy·2026

Prospective evaluation of imipenem trough concentrations and clinical outcomes in critically ill patients.

The Journal of antimicrobial chemotherapy·2026

Liposomal amphotericin B retrospective multicentre study on mycosis prophylaxis (L-AmB_RUSCO): tolerability and safety of extended-dosing primary antifungal prophylaxis in children with newly diagnosed acute myeloid leukaemia.

The Journal of antimicrobial chemotherapy·2026

Humanizing meropenem dosage regimens by co-administration of cilastatin in an immunocompetent mouse bloodstream infection model of Acinetobacter baumannii based on a novel quantitative matching framework.

The Journal of antimicrobial chemotherapy·2026

Recent Developments and Structure-Activity Relationships of BRAF Inhibitors for Cancer Drug Discovery.

Archiv der Pharmazie·2026

Sequential soxhlet fractionation of Cistus ladanifer L. reveals a polarity-activity gradient: GC-MS profiling, multimechanistic bioactivity, and in silico identification of antifungal and antibacterial lead compounds.

Frontiers in chemistry·2026

Novel Benzofuran Derivatives as SARM1 Inhibitors for Treating Axonal Degeneration.

ACS medicinal chemistry letters·2026

Novel Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer.

ACS medicinal chemistry letters·2026

Structure-Activity Relationship Studies Resulting in the Identification of Potent and Selective Salt-Inducible Kinase Inhibitors.

ACS medicinal chemistry letters·2026

Structural Preferences and ADMET Regulation of Fluorinated Small-Molecule Drugs.

ACS medicinal chemistry letters·2026

Related Experiment Videos

In vitro activity and serum protein-binding of cefaclor

Related Concept Videos

Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.

Activity of a novel cyclic lipopeptide, CB-183,315, against resistant Clostridium difficile and other Gram-positive aerobic and anaerobic intestinal pathogens.

Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.

Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.

Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis.

Performance of plasma separation cards for HIV drug-resistance genotyping in a resource-limited setting: comparison with plasma samples.

Antibiotic consumption in HIV and PrEP populations with and without sexually transmitted infections: a population-based observational study.

Prospective evaluation of imipenem trough concentrations and clinical outcomes in critically ill patients.

Liposomal amphotericin B retrospective multicentre study on mycosis prophylaxis (L-AmB_RUSCO): tolerability and safety of extended-dosing primary antifungal prophylaxis in children with newly diagnosed acute myeloid leukaemia.

Humanizing meropenem dosage regimens by co-administration of cilastatin in an immunocompetent mouse bloodstream infection model of Acinetobacter baumannii based on a novel quantitative matching framework.

Recent Developments and Structure-Activity Relationships of BRAF Inhibitors for Cancer Drug Discovery.

Sequential soxhlet fractionation of Cistus ladanifer L. reveals a polarity-activity gradient: GC-MS profiling, multimechanistic bioactivity, and in silico identification of antifungal and antibacterial lead compounds.

Novel Benzofuran Derivatives as SARM1 Inhibitors for Treating Axonal Degeneration.

Novel Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer.

Structure-Activity Relationship Studies Resulting in the Identification of Potent and Selective Salt-Inducible Kinase Inhibitors.

Structural Preferences and ADMET Regulation of Fluorinated Small-Molecule Drugs.

Related Experiment Videos

In vitro activity and serum protein-binding of cefaclor

Related Concept Videos

Related Articles